Logo image of ALHUN.PA

HUNYVERS SACA (ALHUN.PA) Stock Fundamental Analysis

Europe - EPA:ALHUN - FR0014007LQ2 - Common Stock

7.34 EUR
+0.02 (+0.27%)
Last: 10/22/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALHUN. ALHUN was compared to 53 industry peers in the Specialty Retail industry. There are concerns on the financial health of ALHUN while its profitability can be described as average. ALHUN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ALHUN was profitable.
In the past year ALHUN has reported a negative cash flow from operations.
Each year in the past 5 years ALHUN has been profitable.
Of the past 5 years ALHUN 4 years had a positive operating cash flow.
ALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALHUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M 6M

1.2 Ratios

ALHUN's Return On Assets of 1.92% is in line compared to the rest of the industry. ALHUN outperforms 56.60% of its industry peers.
With a decent Return On Equity value of 7.12%, ALHUN is doing good in the industry, outperforming 62.26% of the companies in the same industry.
ALHUN has a Return On Invested Capital of 5.97%. This is in the better half of the industry: ALHUN outperforms 62.26% of its industry peers.
ALHUN had an Average Return On Invested Capital over the past 3 years of 9.61%. This is in line with the industry average of 10.25%.
Industry RankSector Rank
ROA 1.92%
ROE 7.12%
ROIC 5.97%
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ALHUN.PA Yearly ROA, ROE, ROICALHUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

ALHUN's Profit Margin of 1.41% is in line compared to the rest of the industry. ALHUN outperforms 58.49% of its industry peers.
In the last couple of years the Profit Margin of ALHUN has declined.
Looking at the Operating Margin, with a value of 2.48%, ALHUN is in line with its industry, outperforming 49.06% of the companies in the same industry.
ALHUN's Operating Margin has declined in the last couple of years.
ALHUN has a worse Gross Margin (19.99%) than 73.58% of its industry peers.
In the last couple of years the Gross Margin of ALHUN has grown nicely.
Industry RankSector Rank
OM 2.48%
PM (TTM) 1.41%
GM 19.99%
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
ALHUN.PA Yearly Profit, Operating, Gross MarginsALHUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

ALHUN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ALHUN has about the same amount of shares outstanding.
The number of shares outstanding for ALHUN has been increased compared to 5 years ago.
ALHUN has a worse debt/assets ratio than last year.
ALHUN.PA Yearly Shares OutstandingALHUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALHUN.PA Yearly Total Debt VS Total AssetsALHUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALHUN has an Altman-Z score of 2.18. This is not the best score and indicates that ALHUN is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ALHUN (2.18) is comparable to the rest of the industry.
ALHUN has a Debt/Equity ratio of 0.72. This is a neutral value indicating ALHUN is somewhat dependend on debt financing.
The Debt to Equity ratio of ALHUN (0.72) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z 2.18
ROIC/WACC0.93
WACC6.39%
ALHUN.PA Yearly LT Debt VS Equity VS FCFALHUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M 20M

2.3 Liquidity

ALHUN has a Current Ratio of 1.50. This is a normal value and indicates that ALHUN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.50, ALHUN is in the better half of the industry, outperforming 71.70% of the companies in the same industry.
A Quick Ratio of 0.29 indicates that ALHUN may have some problems paying its short term obligations.
ALHUN has a worse Quick ratio (0.29) than 86.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 0.29
ALHUN.PA Yearly Current Assets VS Current LiabilitesALHUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

The earnings per share for ALHUN have decreased strongly by -53.14% in the last year.
The Earnings Per Share has been decreasing by -8.23% on average over the past years.
The Revenue has grown by 15.96% in the past year. This is quite good.
ALHUN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.45% yearly.
EPS 1Y (TTM)-53.14%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ALHUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.26% yearly.
ALHUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.44% yearly.
EPS Next Y-19.73%
EPS Next 2Y15.18%
EPS Next 3Y17.59%
EPS Next 5Y25.26%
Revenue Next Year-0.83%
Revenue Next 2Y3.79%
Revenue Next 3Y4.06%
Revenue Next 5Y4.44%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALHUN.PA Yearly Revenue VS EstimatesALHUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M
ALHUN.PA Yearly EPS VS EstimatesALHUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

ALHUN is valuated correctly with a Price/Earnings ratio of 15.29.
Based on the Price/Earnings ratio, ALHUN is valued cheaper than 81.13% of the companies in the same industry.
ALHUN is valuated rather cheaply when we compare the Price/Earnings ratio to 27.57, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.31, the valuation of ALHUN can be described as very cheap.
84.91% of the companies in the same industry are more expensive than ALHUN, based on the Price/Forward Earnings ratio.
ALHUN is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.29
Fwd PE 7.31
ALHUN.PA Price Earnings VS Forward Price EarningsALHUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ALHUN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.02
ALHUN.PA Per share dataALHUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as ALHUN's earnings are expected to grow with 17.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y17.59%

0

5. Dividend

5.1 Amount

No dividends for ALHUN!.
Industry RankSector Rank
Dividend Yield N/A

HUNYVERS SACA

EPA:ALHUN (10/22/2025, 7:00:00 PM)

7.34

+0.02 (+0.27%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.77%
Inst Owner ChangeN/A
Ins Owners2.63%
Ins Owner ChangeN/A
Market Cap28.41M
Revenue(TTM)130.33M
Net Income(TTM)1.84M
Analysts88
Price Target10.56 (43.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-26.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.2%
Valuation
Industry RankSector Rank
PE 15.29
Fwd PE 7.31
P/S 0.22
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 2.45
EV/EBITDA 11.02
EPS(TTM)0.48
EY6.54%
EPS(NY)1
Fwd EY13.68%
FCF(TTM)-0.91
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS33.68
BVpS6.67
TBVpS2.99
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.49
Profitability
Industry RankSector Rank
ROA 1.92%
ROE 7.12%
ROCE 7.25%
ROIC 5.97%
ROICexc 6.69%
ROICexgc 10.28%
OM 2.48%
PM (TTM) 1.41%
GM 19.99%
FCFM N/A
ROA(3y)4.38%
ROA(5y)3.79%
ROE(3y)13.52%
ROE(5y)19.81%
ROIC(3y)9.61%
ROIC(5y)8.35%
ROICexc(3y)11.28%
ROICexc(5y)11.76%
ROICexgc(3y)15.77%
ROICexgc(5y)16.95%
ROCE(3y)12.12%
ROCE(5y)10.83%
ROICexgc growth 3Y-40.67%
ROICexgc growth 5YN/A
ROICexc growth 3Y-38.4%
ROICexc growth 5YN/A
OM growth 3Y-16.85%
OM growth 5YN/A
PM growth 3Y-26.74%
PM growth 5YN/A
GM growth 3Y2.73%
GM growth 5YN/A
F-Score3
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA 4.34
Cap/Depr 62.91%
Cap/Sales 0.5%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 0.29
Altman-Z 2.18
F-Score3
WACC6.39%
ROIC/WACC0.93
Cap/Depr(3y)138.87%
Cap/Depr(5y)108.48%
Cap/Sales(3y)0.8%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.14%
EPS 3Y-8.23%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-19.73%
EPS Next 2Y15.18%
EPS Next 3Y17.59%
EPS Next 5Y25.26%
Revenue 1Y (TTM)15.96%
Revenue growth 3Y26.45%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-0.83%
Revenue Next 2Y3.79%
Revenue Next 3Y4.06%
Revenue Next 5Y4.44%
EBIT growth 1Y-40.36%
EBIT growth 3Y5.15%
EBIT growth 5YN/A
EBIT Next Year14.89%
EBIT Next 3Y20.87%
EBIT Next 5Y24.22%
FCF growth 1Y33.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y33.49%
OCF growth 3YN/A
OCF growth 5YN/A